Clinical trials
Completed Univentricular Heart trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2013 | 7 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Children's Hospital | 6 |
| Children's Hospital of Philadelphia | 3 |
| Children's Mercy Hospital Kansas City | 3 |
| Emory University | 3 |
| University Hospital, Montpellier | 3 |
| Hacettepe University | 2 |
| Okayama University | 2 |
| University of Aarhus | 2 |
| University of Sao Paulo | 2 |
| Carelon Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Univentricular Heart | 47 |
| Heart Defects, Congenital | 23 |
| Hypoplastic Left Heart Syndrome | 10 |
| Heart Failure | 4 |
| Lymphatic Abnormalities | 3 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 2 |
| Hypertension, Pulmonary | 1 |
| Infant, Newborn, Diseases | 1 |
| Infant, Premature, Diseases | 1 |
| Lymphedema | 1 |
Trials
Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.